<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=780280282443813&amp;ev=PageView&amp;noscript=1">
search

    BioLineRx Ltd.

    verified_userVerify Profile
    Companies » Health Care » Pharmaceuticals & Biotechnology » Pharmaceuticals

    About BioLineRx Ltd.

    BioLineRx is a clinical-stage biopharmaceutical company focused on oncology. The Company in-licenses novel compounds, develops them through pre-clinical and/or clinical stages, and then partners with pharmaceutical companies for advanced clinical development and/or commercialization. Source

    At A Glance

    • CAPITAL RAISE STATUS
      Not Currently Raising
    • FILING TYPE
      Public
    • PLATFORM TYPE
      NASDAQ
    • RAISED AMOUNT
      $X,XXX,XXX
    • PRE-MONEY EVAULATION
      $X,XXX,XXX
    • SIC CODE
      2834
    • NIN CODE
      ####
    • LEADERSHIP
      Philip A. Serlin, CPA, MBA
    • FOUNDED
      2003
    • EMPLOYEES
      20
    • SECTOR
      Pharmaceuticals & Biotechnology
    • SUBSECTOR
      Pharmaceuticals

    Company Tags

    No articles found.

    Satsuma Pharmaceuticals, Inc.

    Satsuma Pharmaceuticals, Inc.

    With operations in South San Francisco, CA and Research Triangle Park, NC, Satsuma...

    With operations in South San Francisco, CA and ...

    Filing Type:    PU
    RehabPath Inc.

    RehabPath Inc.

    We exist to make the first step in a family’s path to recovery the right step thro...

    We exist to make the first step in a family’s p...

    Amount Raised:    $26,162.00
    Fundraising Status:    EC
    Filing Type:    CF
    CRISPR Therapeutics AG

    CRISPR Therapeutics AG

    We are rapidly translating our specific, efficient and versatile CRISPR/Cas9 gene-...

    We are rapidly translating our specific, effici...

    Filing Type:    PU
    Evofem Biosciences, Inc.

    Evofem Biosciences, Inc.

    Evofem BiosciencesÂŽ exists to advance the lives of women. We believe this work ce...

    Evofem BiosciencesÂŽ exists to advance the live...

    Filing Type:    PU
    Amicus Therapeutics, Inc.

    Amicus Therapeutics, Inc.

    Amicus Therapeutics (Nasdaq: FOLD) is a global, patient-centric biotechnology comp...

    Amicus Therapeutics (Nasdaq: FOLD) is a global,...

    Filing Type:    PU
    Aytu BioScience, Inc.

    Aytu BioScience, Inc.

    Aytu is committed to better health for men and women here at home and worldwide. W...

    Aytu is committed to better health for men and ...

    Filing Type:    PU
    Merus N.V.

    Merus N.V.

    Merus is a clinical-stage immuno-oncology company developing innovative full-lengt...

    Merus is a clinical-stage immuno-oncology compa...

    Filing Type:    PU
    Molecular Templates, Inc.

    Molecular Templates, Inc.

    Molecular Templates is focused on the discovery, development, and commercializatio...

    Molecular Templates is focused on the discovery...

    Filing Type:    PU
    Aptose Biosciences, Inc.

    Aptose Biosciences, Inc.

    Aptose Biosciences is a clinical-stage biotechnology company developing personaliz...

    Aptose Biosciences is a clinical-stage biotechn...

    Filing Type:    PU
    ©2026 National Investor Network. All Rights Reserved.